Literature DB >> 16271760

Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias.

Mitsue Inomata1, Shinichiro Takahashi, Hideo Harigae, Junichi Kameoka, Mitsuo Kaku, Takeshi Sasaki.   

Abstract

Over-expression of the Flt3 is prevalent in acute myeloblastic leukemia (AML), playing a role in leukemogenesis while decreased expression of PU.1 induces AML in mice model. Therefore, we speculated that there is an inverse relationship between these two factors. To clarify this, we measured the expression level of Flt3 and PU.1 in 24 primary AML specimens. As a result, there is a significant negative correlation between Flt3 and PU.1 (r=-0.43, p<0.05). Furthermore, we revealed that flt3 gene promoter is suppressed by the over-expression of PU.1, suggesting that PU.1 is a potential suppressor of flt3 gene promoter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271760     DOI: 10.1016/j.leukres.2005.07.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  Synergistic effect of arsenic trioxide and flt3 inhibition on cells with flt3 internal tandem duplication.

Authors:  Shinichiro Takahashi; Hideo Harigae; Hisayuki Yokoyama; Izumi Ishikawa; Shouri Abe; Masue Imaizumi; Takeshi Sasaki; Mitsuo Kaku
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

2.  Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells.

Authors:  Akemi Imoto; Mami Okada; Toshio Okazaki; Hidero Kitasato; Hideo Harigae; Shinichiro Takahashi
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

3.  Role of hypoxia in the regulation of periovulatory EDN2 expression in the mouse.

Authors:  Giyoun Na; Phillip J Bridges; Yongbum Koo; CheMyong Ko
Journal:  Can J Physiol Pharmacol       Date:  2008-06       Impact factor: 2.273

Review 4.  Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications.

Authors:  Shinichiro Takahashi
Journal:  J Hematol Oncol       Date:  2011-04-01       Impact factor: 17.388

5.  Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia.

Authors:  C-H Olme; R Finnon; N Brown; S Kabacik; S D Bouffler; C Badie
Journal:  Leuk Res       Date:  2013-06-25       Impact factor: 3.156

6.  Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.

Authors:  Houda Alachkar; Ramasamy Santhanam; Jason G Harb; David M Lucas; Joshua J Oaks; Christopher J Hickey; Li Pan; A Douglas Kinghorn; Michael A Caligiuri; Danilo Perrotti; John C Byrd; Ramiro Garzon; Michael R Grever; Guido Marcucci
Journal:  J Hematol Oncol       Date:  2013-03-16       Impact factor: 17.388

Review 7.  Molecular functions of metallothionein and its role in hematological malignancies.

Authors:  Shinichiro Takahashi
Journal:  J Hematol Oncol       Date:  2012-07-27       Impact factor: 17.388

8.  TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality.

Authors:  Jue Wang; Tongjuan Li; Mi Zhou; Zheng Hu; Xiaoxi Zhou; Shiqiu Zhou; Na Wang; Liang Huang; Lei Zhao; Yang Cao; Min Xiao; Ding Ma; Pengfei Zhou; Zhen Shang; Jianfeng Zhou
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

9.  A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiation.

Authors:  Naomi Hirako; Hiroko Nakano; Shinichiro Takahashi
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.